Analysis identifies hub genes related to immune cells in ARDS, suggesting new therapeutic targets.
This study first systematically identified EXORDEGs in ARDS, discovering four hub genes and their associations with immune cells. The hub genes may be implicated in endothelial injury, inflammation, and immune dysregulation. These findings provide novel insights into ARDS pathogenesis and highlight potential therapeutic targets for further investigation. Given the disease heterogeneity, our findings primarily reflect common molecular characteristics, while the specific features of different etiological subtypes require further investigation.
No takes yet. Share an insight, caveat, or question.
Tu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: